GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Friulchem SpA (MIL:FCM) » Definitions » Loans Receivable

Friulchem SpA (MIL:FCM) Loans Receivable : €0.00 Mil (As of Jun. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Friulchem SpA Loans Receivable?

Friulchem SpA's Loans Receivable for the quarter that ended in Jun. 2023 was €0.00 Mil.


Friulchem SpA Loans Receivable Historical Data

The historical data trend for Friulchem SpA's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Friulchem SpA Loans Receivable Chart

Friulchem SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial - - - - -

Friulchem SpA Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Friulchem SpA Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Friulchem SpA Loans Receivable Related Terms

Thank you for viewing the detailed overview of Friulchem SpA's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Friulchem SpA (MIL:FCM) Business Description

Traded in Other Exchanges
N/A
Address
Via Carlo Ravizza 40, Milano, ITA, 20149
Friulchem SpA is an Italy based company engaged in pharma business. It is involved in research, development, and production of generic finished products such as cosmeceuticals and food supplements. The company is also involved in the manufacturing of vet-pharma products.

Friulchem SpA (MIL:FCM) Headlines

No Headlines